Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Applied and Environmental Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Microbial Ecology

Tumor Necrosis Factor Alpha Modulates the Dynamics of the Plasminogen-Mediated Early Interaction between Bifidobacterium animalis subsp. lactis and Human Enterocytes

Manuela Centanni, Simone Bergmann, Silvia Turroni, Sven Hammerschmidt, Gursharan Singh Chhatwal, Patrizia Brigidi, Marco Candela
Manuela Centanni
aDepartment of Pharmaceutical Sciences, University of Bologna, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Bergmann
bDepartment of Infection Biology, Institute for Microbiology, Technische Universität Braunschweig, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Turroni
aDepartment of Pharmaceutical Sciences, University of Bologna, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Hammerschmidt
cDepartment of Genetics of Microorganisms, Interfaculty Institute for Genetics and Functional Genomics, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gursharan Singh Chhatwal
dDepartment of Medical Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrizia Brigidi
aDepartment of Pharmaceutical Sciences, University of Bologna, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Candela
aDepartment of Pharmaceutical Sciences, University of Bologna, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AEM.07883-11
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The capacity to intervene with the host plasminogen system has recently been considered an important component in the interaction process between Bifidobacterium animalis subsp. lactis and the human host. However, its significance in the bifidobacterial microecology within the human gastrointestinal tract is still an open question. Here we demonstrate that human plasminogen favors the B. animalis subsp. lactis BI07 adhesion to HT29 cells. Prompting the HT29 cell capacity to activate plasminogen, tumor necrosis factor alpha (TNF-α) modulated the plasminogen-mediated bacterium-enterocyte interaction, reducing the bacterial adhesion to the enterocytes and enhancing migration to the luminal compartment.

TEXT

Bifidobacterium is an important, occasionally dominant, genus of the human intestinal microbiota whose presence in the human gastrointestinal tract (GIT) has been associated with several health benefits (12, 17). Merging health-promoting activities and technological properties, B. animalis subsp. lactis is one of the most common probiotic species in North America and Europe (3). Because of the wide probiotic usage of this bacterium, different studies with the goal of better comprehending the molecular mechanisms involved in the bacterium-host interaction process have been recently carried out (3, 11). In this scenario, the capacity of this microorganism to intervene with the host plasmin(ogen) system has been recently regarded as a possible actor in the interplay with human enterocytes (11, 28). However, the role of the human plasminogen (Plg) system in the biology of the Bifidobacterium-host interaction process is still to be determined. The 92-kDa Plg is the monomeric proenzyme of the serine protease plasmin. Plg comprises an N-terminal ∼8-kDa preactivation peptide, five consecutive disulfide-bonded kringle domains (65 kDa) that mediate binding to lysine-containing protein receptors, and a serine protease domain (25 kDa). Although Plg is produced mainly by hepatocytes, other tissue sources of Plg, including the intestine, have been identified (41). Plg is immobilized onto lysine-containing cell surface protein receptors such as fibrin as well as components of the extracellular matrix. Plg activation is a process tightly regulated by the balance between Plg activators (PAs), such as urokinase (uPA) and tissue-type (tPA) activators, and their specific inhibitors, PAI-1/2. Involved in fibrinolysis, enhancement of cell migration, and damages of tissue barriers, the Plg system has a key role in several human physiological and pathological processes (27).

We previously reported the capability of B. animalis subsp. lactis to bind human plasmin(ogen) (8). Plg binding to the bifidobacterial cell surface is mediated by five cell wall protein receptors: DnaK, glutamine synthetase, enolase, bile salt hydrolase, and phosphoglycerate mutase. According to Candela et al. (7), in the presence of Plg and host PAs, B. animalis subsp. lactis acquires a surface-bound Plg-derived proteolytic activity effective in the degradation of host physiological substrates. This modality of interaction with the components of the host Plg system resembles the one characteristic of several enteropathogens, such as Salmonella enterica, Listeria monocytogenes, and Escherichia coli (16, 25, 29, 30, 32, 36). Different from the case for Bifidobacterium, the role of Plg in bacterial pathogens has been determined, and the bacterial capacity to intervene with the host Plg system has been traditionally considered a paradigm of pathogenicity (5, 16, 25, 29, 30, 32, 35). Facilitating the bacterial transmigration through epithelial monolayers, for pathogens, the acquisition of a Plg-dependent surface-associated plasmin activity is necessary for dissemination in the host tissues. This process has been defined as bacterial metastasis in analogy to the role of Plg in tumor cell invasion (10, 31). Originally isolated from fermented milk (19) and commonly found in the gut of healthy adults and infants (38), B. animalis subsp. lactis has been shown to possess a mutualistic nature, and its capacity to intervene with the host Plg system must serve a different purpose than the bacterial metastasis (7). Consequently, even if B. animalis subsp. lactis and pathogens show the same modality of interaction with the components of the host Plg system, the outcome of Plg-binding activity in the biology of interaction with the host must be different, and comprehension of its significance in bifidobacterial ecology is needed. In this work, we studied the role of the human Plg system in the early interaction process between B. animalis subsp. lactis BI07 and the human enterocyte line HT29 (26). Moreover, since gastrointestinal inflammatory processes involve unbalances of the components of the host Plg system (14, 20, 23), we investigated the impact of the proinflammatory cytokine tumor necrosis factor alpha (TNF-α) on the dynamics of the Plg-mediated B. animalis subsp. lactis BI07-HT29 cell early interaction. TNF-α was selected because this cytokine has been reported to play a central role in intestinal inflammation (18, 40).

HT29 cell culture conditions.HT29 cells were grown in Dulbecco's modified Eagle's minimal essential medium with 4.5 g/liter glucose (DMEM; PAA Laboratories) as reported by O'Hara et al. (22). For adhesion and intracellular invasion assays, 2.5 × 105 HT29 cells per well were seeded in 24-well tissue culture plates (TPP) and 12-mm-diameter glass coverslips and grown to confluent monolayers. For the transmigration assay, 1 × 105 cells were layered on 3-μm-pore size transwell inserts (Falcon; Becton Dickinson) in 24-well tissue culture plates and allowed to grow to confluent and fully differentiated monolayers. The tightness of the cell layers was verified as described by Attali et al. (2). Twenty-four hours before each assay, the cell medium was replaced with interaction medium (IM) (DMEM, 25 mM HEPES, 1 g/liter glucose [Gibco], 1% fetal calf serum [FCS]); when necessary, 2 ng/ml human recombinant TNF-α (Thermo Scientific) was added to induce a proinflammatory response (22).

Role of human Plg in the interaction process of B. animalis subsp. lactis BI07 and HT29 cells.To assess whether the HT29 cell endogenous Plg contributed to the early interaction between B. animalis subsp. lactis BI07 and HT29 cells, the impact of the enterocyte pretreatment with polyclonal goat anti-human Plg IgG (Kordia) (5 μg/ml) on B. animalis subsp. lactis BI07 adhesion was determined. B. animalis subsp. lactis BI07 adhesion to HT29 monolayers was measured by quantitative PCR (qPCR) as reported by Candela et al. (9). For each experimental condition, six independent replica experiments were performed. According to our data, the anti-human Plg pretreatment resulted in a slight, but not significant (P > 0.05), decrease of the bifidobacterial adhesion to the enterocyte surface (−16%). These data indicated that the endogenously produced Plg of HT29 cells exerted only a minimal contribution to the B. animalis subsp. lactis BI07-HT29 cell adhesion process. Consequently, in order to investigate the role of human Plg in the B. animalis subsp. lactis BI07-enterocyte interaction process, bacterial cells were preincubated with human Plg (Sigma) as reported by Attali et al. (2) and then subjected to a conventional HT29 cell adhesion assay (9). Thirty-minute preincubation at 37°C with 100 μg/ml human Plg significantly enhanced B. animalis subsp. lactis BI07 adhesion to HT29 cells (+225%; P < 0.001) (Table 1). The incubation of Plg-pretreated B. animalis subsp. lactis BI07 cells with 5 μg/ml anti-human Plg IgG resulted in the complete abolition of the Plg contribution to the bifidobacterial adhesion to the HT29 cell surface. These data demonstrated that human Plg captured on the B. animalis subsp. lactis BI07 cell surface significantly enhanced bacterial adhesion to the host enterocytes. As suggested by Pancholi et al. (24), the bacterium-bound Plg can act as a molecular bridge between bacterial and enterocyte receptors, enhancing bacterial adhesion to the host epithelium. Incubation of Plg-pretreated B. animalis subsp. lactis BI07 cells with 1 μg/ml uPA (Sigma) decreased the HT29 cell adhesion by ∼50% with respect to the value obtained in the absence of uPA (P < 0.001) (Table 1). The addition of 8 U/ml of the plasmin inhibitor aprotinin (Sigma) (2) was effective in the complete recovery of the Plg-dependent enterocyte adhesion of B. animalis subsp. lactis BI07 cells preincubated with Plg plus uPA (Table 1), proving that the acquisition of a cell surface plasmin activity in the presence of uPA was sufficient to dampen the contribution of Plg to the B. animalis subsp. lactis BI07 adhesion to the enterocyte surface.

View this table:
  • View inline
  • View popup
Table 1

qPCR quantification of the Plg-mediated adhesion of B. animalis subsp. lactis BI07 to untreated and TNF-α-pretreated HT29 cells

Next, we investigated HT29 cell internalization and transmigration of untreated, pretreated with Plg or with Plg and uPA B. animalis subsp. lactis BI07 bacteria. Enterocyte internalization was analyzed by double immunofluorescence microscopy, which enables a differential staining of intracellular and adherent bacterial cells, as reported by Bergmann et al. (4). For each experimental condition, three independent adhesion experiments were carried out. Antibodies against B. animalis subsp. lactis BI07 were generated in BALB/c mice according to standard protocols. Microscopic analysis of the whole HT29 cell layer revealed no bacterial internalization by the HT29 enterocyte cell line in any of the tested conditions (Fig. 1A). For comparison and as a control, the internalization of Salmonella enterica serovar Typhimurium by HT29 cells was determined using a gentamicin protection assay (13). S. Typhimurium, provided by A. Essig (Department of Medical Microbiology, University of Ulm, Germany), was cultured as reported by Candela et al. (9). In accordance with data reported by Hess et al. (13), we determined a HT29 cell internalization value of (9.32 ± 1.58) × 104 CFU of S. Typhimurium after 1 h of incubation with 1 × 108 CFU of this microorganism. In order to analyze the B. animalis subsp. lactis BI07 transmigration through HT29 monolayers, a transwell system-based transmigration assay was performed as reported by Attali et al. (2). Untreated, Plg-pretreated, and Plg- and uPA-pretreated B. animalis subsp. lactis BI07 cells showed no transmigration through the HT29 monolayers (data not shown). In a control experiment, the transmigration of S. Typhimurium bacteria across HT29 monolayers was determined. In accordance with the data reported by Hess et al. (13), (7.84 ± 1.03) × 105 bacteria penetrated from the apical compartment to the basal compartment of HT29 cells after 1 h of coincubation with 2 × 107 CFU. These last data proved that in B. animalis subsp. lactis BI07, the acquisition of a surface-associated plasmin activity did not result in enterocyte internalization or bacterial transmigration through enterocyte monolayers, supporting the strict commensal nature of this health-promoting species.

Fig 1
  • Open in new tab
  • Download powerpoint
Fig 1

Intracellular invasion assays of B. animalis subsp. lactis BI07 in untreated (A) and TNF-α-pretreated (B) HT29 cells. HT29 cell monolayers grown to confluence were incubated with 5 × 107 CFU of B. animalis subsp. lactis BI07 untreated (BI07), pretreated with Plg (+Plg) and pretreated with Plg and uPA (+Plg+uPA). Intracellular and adherent bacteria were differentiated by double immunofluorescence microscopy. Adherent B. animalis subsp. lactis BI07 bacteria (indicated by arrows) were stained with mouse antibifidobacterial antiserum followed by a secondary Alexa Fluor 488-conjugated anti-mouse antibody (green). After HT29 cell permeabilization, internalized bacteria were stained with mouse antibifidobacterial antiserum and a secondary Alexa Fluor 568-conjugated anti-mouse antibody (red). HT29 cells are visualized in the corresponding phase-contrast images shown in the lower panel (magnification, ×100). For each experimental condition, the assay was repeated three times. Results of a representative experiment are shown.

Even if the modality of interaction between B. animalis subsp. lactis and the components of the host Plg system resembles the one described for several pathogens (16, 25, 29, 30, 32, 36), our data demonstrated that the consequences of this interaction with respect to host colonization are different. In fact, for both B. animalis subsp. lactis and pathogenic bacteria, cell-bound Plg enhances bacterial adhesion to the host epithelium (2, 24), but in the presence of host PAs, the phenotype of interaction with the host becomes totally different. Different from the case for pathogens, in B. animalis subsp. lactis, the acquisition of surface-associated plasmin activity does not result in pericellular invasion but rather supports bacterial migration to the luminal compartment. Thus, common to symbionts and pathogens (1, 15), the bacterial capacity to intervene with the host Plg system cannot be viewed as a determinant of pathogenicity by itself. Instead, it could be regarded as an ancestral mechanism of bacterium-host interaction evolved prior to the radiation of pathogens from commensals (6, 21). Acting in concert with other virulence attributes (2, 21), the capacity to intervene with the host Plg system appears to be a fundamental prerequisite for host invasion only for pathogens (37).

Impact of TNF-α on the Plg-mediated early interaction between B. animalis subsp. lactis BI07 and HT29 cells.To mimic an inflammatory status, HT29 cell layers were preincubated with the proinflammatory cytokine TNF-α, and their early interaction with Plg- or Plg- and uPA-pretreated and untreated B. animalis subsp. lactis BI07 cells was investigated by qPCR and immunomicroscopic analysis as reported above. Interestingly, we detected only a minor increase of B. animalis subsp. lactis BI07 adhesion in TNF-α-stimulated HT29 monolayers after Plg pretreatment (Table 1). Moreover, after the TNF-α preincubation of HT29 layers, Plg-pretreated and Plg- and uPA-pretreated B. animalis subsp. lactis BI07 cells exhibited comparable adhesion values (Table 1). The addition of aprotinin effectively restored the Plg-dependent B. animalis subsp. lactis BI07 adhesion to TNF-α-stimulated HT29 layers for both Plg- and Plg- and uPA-pretreated B. animalis subsp. lactis BI07 cells (Table 1). Analogous to the data obtained with noninflamed HT29 cells, no bacterial internalization (Fig. 1B) or transmigration (data not shown) was detected when TNF-α-stimulated HT29 cells were incubated with Plg-pretreated, Plg- and uPA-pretreated, and untreated B. animalis subsp. lactis BI07 cells. Taken together, these data indicated that, by enhancing the enterocyte capacity to activate Plg, a TNF-α-mediated inflammatory response can modulate the dynamics of the Plg-mediated early interaction between B. animalis subsp. lactis and human enterocytes, lowering bacterial adhesion to the enterocyte surface and shifting migration to the luminal compartment. Confirming this hypothesis, in a conventional plasmin activity assay (2, 7), we demonstrated that the TNF-α pretreatment increased by 2-fold the HT29 cell capacity to activate Plg (P < 0.001).

Our data suggest that B. animalis subsp. lactis BI07 shows a different phenotype of interaction with the host Plg system depending on the inflammatory status of the host GIT epithelium. While Plg enhances B. animalis subsp. lactis adhesion in a noninflamed GIT epithelium, inflammation would result in the activation of bacterium-bound Plg and mediate the migration of the microorganisms to the luminal compartment. We hypothesize that this particular dynamic of interaction between B. animalis subsp. lactis and the components of the host Plg system could be of some relevance in the bifidobacterial microecology in the human GIT. In noninflamed regions of the human GIT, which represent the suitable ecological niche for B. animalis subsp. lactis, the microorganism can take advantage of the host Plg for the adhesion to the mucosal surface. On the other hand, in inflamed tissue sites, B. animalis subsp. lactis would acquire a surface-associated plasmin activity that, facilitating the bacterial migration to the luminal compartment, could function as a bacterial escape mechanism to circumvent the host inflammatory response. Unable to face inflammation (34), B. animalis subsp. lactis may thus utilize the host Plg system to sense and escape intestinal inflammation, abandoning inflamed gastrointestinal sites in favor of noninflamed ones. Our in vitro model of interaction could explain, at least in part, the observed decrease of the relative abundance of Bifidobacterium in inflammatory bowel disease (IBD) subjects (33, 39).

Conclusions.Investigating the role of Plg in the bifidobacterial biology in the human GIT, our experimental work represents a step forward in the comprehension of the factors that play a role in the dynamics of Bifidobacterium-host interaction in the human GIT. However, our in vitro data need to be confirmed by in vivo studies specifically designed to prove the role of the host Plg system in the inflammation-dependent bifidobacterial decrease in the human GIT. The achievement of this goal will allow a better understanding of the biology of this health-promoting microbiota component in the human GIT.

ACKNOWLEDGMENT

This research was partially supported by a grant from the Italy-Germany Vigoni Program.

We thank Marcus Fulde for performing the mouse immunizations for the antibifidobacterial antiserum.

FOOTNOTES

    • Received 15 December 2011.
    • Accepted 17 January 2012.
    • Accepted manuscript posted online 27 January 2012.
  • Copyright © 2012, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Antikainen J,
    2. Kuparinen V,
    3. Lähteenmäki K,
    4. Korhonen TK
    . 2007. Enolases from Gram-positive bacterial pathogens and commensal lactobacilli share functional similarity in virulence-associated traits. FEMS Immunol. Med. Microbiol. 51: 526–534.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Attali C,
    2. Durmort C,
    3. Vernet T,
    4. Di Guilmi AM
    . 2008. The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect. Immun. 76: 5350–5356.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Barrangou R,
    2. et al
    . 2009. Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04. J. Bacteriol. 191: 4144–4151.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Bergmann S,
    2. et al
    . 2009. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J. Cell Sci. 122: 256–267.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Bergmann S,
    2. Hammerschmidt S
    . 2007. Fibrinolysis and host response in bacterial infections. Thromb. Haemost. 98: 512–520.
    OpenUrlPubMedWeb of Science
  6. 6.↵
    1. Blaser MJ,
    2. Kirschner D
    . 2007. The equilibria that allow bacterial persistence in human hosts. Nature 449: 843–849.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Candela M,
    2. et al
    . 2008. Plasminogen-dependent proteolytic activity in Bifidobacterium lactis. Microbiology 154: 2457–2462.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Candela M,
    2. et al
    . 2007. Binding of human plasminogen to Bifidobacterium. J. Bacteriol. 189: 5929–5936.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Candela M,
    2. et al
    . 2005. Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens. Res. Microbiol. 156: 887–895.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Ertongur S,
    2. et al
    . 2004. Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system. Int. J. Cancer 110: 815–824.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Gilad O,
    2. Svensson B,
    3. Viborg AH,
    4. Stuer-Lauridsen B,
    5. Jacobsen S
    . 2011. The extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12 reveals proteins with putative roles in probiotic effects. Proteomics 11: 2503–2514.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Gill SR,
    2. et al
    . 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Hess DJ,
    2. Henry-Stanley MJ,
    3. Erickson EA,
    4. Wells CL
    . 2002. Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions. J. Surg. Res. 104: 88–94.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Killeen SD,
    2. Wang JH,
    3. Andrews EJ,
    4. Redmond HP
    . 2009. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br. J. Cancer 100: 1589–1602.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Kinnby B,
    2. Booth NA,
    3. Svensäter G
    . 2008. Plasminogen binding by oral streptococci from dental plaque and inflammatory lesions. Microbiology 154: 924–931.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Lähteenmäki K,
    2. Edelman S,
    3. Korhonen TK
    . 2005. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 13: 79–85.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Ley RE,
    2. et al
    . 2008. Evolution of mammals and their gut microbes. Science 320: 1647–1651.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Ma TY,
    2. et al
    . 2004. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G367–G376.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Meile L,
    2. et al
    . 1997. Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated from fermented milk. Syst. Appl. Microbiol. 20: 57–64.
    OpenUrlCrossRefWeb of Science
  20. 20.↵
    1. Mondino A,
    2. Blasi F
    . 2004. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 25: 450–455.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Ochman H,
    2. Lawrence JG,
    3. Groisman EA
    . 2000. Lateral gene transfer and the nature of bacterial innovation. Nature 405: 299–304.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. O'Hara AM,
    2. et al
    . 2006. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118: 202–215.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Okumura S,
    2. et al
    . 2008. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin. Immunol. 130: 175–185.
    OpenUrlPubMed
  24. 24.↵
    1. Pancholi V,
    2. Fontan P,
    3. Jin H
    . 2003. Plasminogen-mediated group A streptococcal adherence to and pericellular invasion of human pharyngeal cells. Microb. Pathog. 35: 293–303.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Parkkinen J,
    2. Korhonen TK
    . 1989. Binding of plasminogen to Escherichia coli adhesion proteins. FEBS Lett. 250: 437–440.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Rousset M
    . 1986. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 68: 1035–1040.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Saksela O,
    2. Rifkin DB
    . 1988. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4: 93–126.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Sánchez B,
    2. Bressollier P,
    3. Urdaci MC
    . 2008. Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host. FEMS Immunol. Med. Microbiol. 54: 1–17.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Schaumburg J,
    2. et al
    . 2004. The cell wall subproteome of Listeria monocytogenes. Proteomics 4: 2991–3006.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Sebbane F,
    2. Jarrett O,
    3. Gardner D,
    4. Long D,
    5. Hinnebusch BJ
    . 2006. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc. Natl. Acad. Sci. U. S. A. 103: 5526–5530.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Setyono-Han B,
    2. et al
    . 2005. Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1. Thromb. Haemost. 93: 779–786.
    OpenUrlPubMed
  32. 32.↵
    1. Sijbrandi R,
    2. et al
    . 2005. Characterization of an iron-regulated alpha-enolase of Bacteroides fragilis. Microbes Infect. 7: 9–18.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Sokol H,
    2. et al
    . 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15: 1183–1189.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Stecher B,
    2. Hardt WD
    . 2008. The role of microbiota in infectious disease. Trends Microbiol. 16: 107–114.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Steinert M,
    2. Hentschel U,
    3. Hacker J
    . 2000. Symbiosis and pathogenesis: evolution of the microbe-host interaction. Naturwissenschaften 87: 1–11.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Sun H
    . 2005. The interaction between pathogens and host coagulation system. Physiology 21: 281–288.
    OpenUrlCrossRef
  37. 37.↵
    1. Sun H,
    2. et al
    . 2004. Plasminogen is a critical factor for group A streptococcal infection. Science 305: 1283–1286.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Turroni F,
    2. et al
    . 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75: 1534–1545.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Veiga P,
    2. et al
    . 2010. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. U. S. A. 107: 18132–18137.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Yan Y,
    2. et al
    . 2008. Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation. Am. J. Pathol. 173: 1013–1028.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Zhang L,
    2. et al
    . 2002. Plasminogen has a broad extrahepatic distribution. Thromb. Haemost. 87: 493–501.
    OpenUrlPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Tumor Necrosis Factor Alpha Modulates the Dynamics of the Plasminogen-Mediated Early Interaction between Bifidobacterium animalis subsp. lactis and Human Enterocytes
Manuela Centanni, Simone Bergmann, Silvia Turroni, Sven Hammerschmidt, Gursharan Singh Chhatwal, Patrizia Brigidi, Marco Candela
Applied and Environmental Microbiology Mar 2012, 78 (7) 2465-2469; DOI: 10.1128/AEM.07883-11

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Applied and Environmental Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Necrosis Factor Alpha Modulates the Dynamics of the Plasminogen-Mediated Early Interaction between Bifidobacterium animalis subsp. lactis and Human Enterocytes
(Your Name) has forwarded a page to you from Applied and Environmental Microbiology
(Your Name) thought you would be interested in this article in Applied and Environmental Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tumor Necrosis Factor Alpha Modulates the Dynamics of the Plasminogen-Mediated Early Interaction between Bifidobacterium animalis subsp. lactis and Human Enterocytes
Manuela Centanni, Simone Bergmann, Silvia Turroni, Sven Hammerschmidt, Gursharan Singh Chhatwal, Patrizia Brigidi, Marco Candela
Applied and Environmental Microbiology Mar 2012, 78 (7) 2465-2469; DOI: 10.1128/AEM.07883-11
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AEM
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AppEnvMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

 

Print ISSN: 0099-2240; Online ISSN: 1098-5336